These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 34742016)

  • 21. Screening strategies to identify HSP70 modulators to treat Alzheimer's disease.
    Repalli J; Meruelo D
    Drug Des Devel Ther; 2015; 9():321-31. PubMed ID: 25609918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tau protein aggregation in Alzheimer's disease: An attractive target for the development of novel therapeutic agents.
    Jouanne M; Rault S; Voisin-Chiret AS
    Eur J Med Chem; 2017 Oct; 139():153-167. PubMed ID: 28800454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel small molecule therapeutic agents for Alzheimer disease: Focusing on BACE1 and multi-target directed ligands.
    Iraji A; Khoshneviszadeh M; Firuzi O; Khoshneviszadeh M; Edraki N
    Bioorg Chem; 2020 Apr; 97():103649. PubMed ID: 32101780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Privileged Pharmacophore of FDA Approved Drugs in Combination with Chalcone Framework: A New Hope for Alzheimer's Treatment.
    Mathew B
    Comb Chem High Throughput Screen; 2020; 23(9):842-846. PubMed ID: 32723232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis and biological evaluation of rasagiline-clorgyline hybrids as novel dual inhibitors of monoamine oxidase-B and amyloid-β aggregation against Alzheimer's disease.
    Xie SS; Liu J; Tang C; Pang C; Li Q; Qin Y; Nong X; Zhang Z; Guo J; Cheng M; Tang W; Liang N; Jiang N
    Eur J Med Chem; 2020 Sep; 202():112475. PubMed ID: 32652406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular Insight into the Therapeutic Promise of Flavonoids against Alzheimer's Disease.
    Uddin MS; Kabir MT; Niaz K; Jeandet P; Clément C; Mathew B; Rauf A; Rengasamy KRR; Sobarzo-Sánchez E; Ashraf GM; Aleya L
    Molecules; 2020 Mar; 25(6):. PubMed ID: 32168835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of benzamide-hydroxypyridinone hybrids as potent multi-targeting agents for the treatment of Alzheimer's disease.
    Jiang X; Guo J; Zhang C; Gu J; Zhou T; Bai R; Xie Y
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):2045-2054. PubMed ID: 34607518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multi-targeting Strategies for Alzheimer's Disease Therapeutics: Pros and Cons.
    Das S; Basu S
    Curr Top Med Chem; 2017; 17(27):3017-3061. PubMed ID: 28685694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multifunctional 5,6-dimethoxybenzo[d]isothiazol-3(2H)-one-N-alkylbenzylamine derivatives with acetylcholinesterase, monoamine oxidases and β-amyloid aggregation inhibitory activities as potential agents against Alzheimer's disease.
    Xu R; Xiao G; Li Y; Liu H; Song Q; Zhang X; Yang Z; Zheng Y; Tan Z; Deng Y
    Bioorg Med Chem; 2018 May; 26(8):1885-1895. PubMed ID: 29500132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-alkylpiperidine carbamates as potential anti-Alzheimer's agents.
    Košak U; Strašek N; Knez D; Jukič M; Žakelj S; Zahirović A; Pišlar A; Brazzolotto X; Nachon F; Kos J; Gobec S
    Eur J Med Chem; 2020 Jul; 197():112282. PubMed ID: 32380361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent Studies on Design and Development of Drugs Against Alzheimer's Disease (AD) Based on Inhibition of BACE-1 and Other AD-causative Agents.
    Gupta SP; Patil VM
    Curr Top Med Chem; 2020; 20(13):1195-1213. PubMed ID: 32297584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Small molecule therapeutics for tauopathy in Alzheimer's disease: Walking on the path of most resistance.
    Wang L; Bharti ; Kumar R; Pavlov PF; Winblad B
    Eur J Med Chem; 2021 Jan; 209():112915. PubMed ID: 33139110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Huprine Y - Tryptophan heterodimers with potential implication to Alzheimer's disease treatment.
    Mezeiova E; Hrabinova M; Hepnarova V; Jun D; Janockova J; Muckova L; Prchal L; Kristofikova Z; Kucera T; Gorecki L; Chalupova K; Kunes J; Hroudova J; Soukup O; Korabecny J
    Bioorg Med Chem Lett; 2021 Jul; 43():128100. PubMed ID: 33984470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design and synthesis of novel tacrine-dipicolylamine dimers that are multiple-target-directed ligands with potential to treat Alzheimer's disease.
    Zhang P; Wang Z; Mou C; Zou J; Xie Y; Liu Z; Benjamin Naman C; Mao Y; Wei J; Huang X; Dong J; Yang M; Wang N; Jin H; Liu F; Lin D; Liu H; Zhou F; He S; Zhang B; Cui W
    Bioorg Chem; 2021 Nov; 116():105387. PubMed ID: 34628225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Recent Look into Natural Products that have Potential to Inhibit Cholinesterases and Monoamine Oxidase B: Update for 2010-2019.
    Gulcan HO; Orhan IE
    Comb Chem High Throughput Screen; 2020; 23(9):862-876. PubMed ID: 31985374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent advances in the neurobiology and neuropharmacology of Alzheimer's disease.
    Kumar K; Kumar A; Keegan RM; Deshmukh R
    Biomed Pharmacother; 2018 Feb; 98():297-307. PubMed ID: 29274586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure-Guided Design of
    Svobodova B; Pulkrabkova L; Panek D; Misiachna A; Kolcheva M; Andrys R; Handl J; Capek J; Nyvltova P; Rousar T; Prchal L; Hepnarova V; Hrabinova M; Muckova L; Tosnerova D; Karabanovich G; Finger V; Soukup O; Horak M; Korabecny J
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Triazole derivatives as inhibitors of Alzheimer's disease: Current developments and structure-activity relationships.
    Xu M; Peng Y; Zhu L; Wang S; Ji J; Rakesh KP
    Eur J Med Chem; 2019 Oct; 180():656-672. PubMed ID: 31352246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of Withaferin A and Its Derivatives in the Management of Alzheimer's Disease: Recent Trends and Future Perspectives.
    Das R; Rauf A; Akhter S; Islam MN; Emran TB; Mitra S; Khan IN; Mubarak MS
    Molecules; 2021 Jun; 26(12):. PubMed ID: 34204308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Comprehensive Review on Potential Molecular Drug Targets for the Management of Alzheimer's Disease.
    Sharma C; Mazumder A
    Cent Nerv Syst Agents Med Chem; 2024; 24(1):45-56. PubMed ID: 38305393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.